Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

CBDL

CBD Life Sciences Inc.

USD

Set alert

Price alert · CBDL

All alert types
0.00 USD 0.00 0.00%
As of Oct 30, 2026
0.0001 Day range 0.0001
0.0001 52-week range 0.0004
YTD
-50.00%
1 year
0.00%
Open
0.0001
Prev close
0.0001
Mkt cap
611.06K
Vol
1.00M
Avg vol
8.82M
EPS
0.00
P/E
0.00
More statistics
Low
0.0001
High
0.0001

5D chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The five-day price history for CBDL has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

-3.89 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

4 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

D+1 / 5 overall

  • DCF 1
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 2

Valuation

P/E -16.8×
FY 2016: -0.0×FY 2017: 0.0×FY 2018: -0.0×FY 2019: -1266×FY 2020: -5556×FY 2021: -25000×FY 2022: -50000×FY 2023: -5000×FY 2024: -2.5×FY 2025: -16.8×
FY 2016 5y median -5000× FY 2025
P/S 8.4×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.1×FY 2019: 13606×FY 2020: 41381×FY 2021: 207527×FY 2022: 254031×FY 2023: 2435×FY 2024: 14.2×FY 2025: 8.4×
FY 2016 5y median 2435× FY 2025
P/B 1.1×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 2.1×FY 2019: 1051×FY 2020: -458677×FY 2021: 9226×FY 2022: 86031×FY 2023: 1032×FY 2024: 3.9×FY 2025: 1.1×
FY 2016 5y median 1032× FY 2025
P/FCF -5.9×
FY 2016: -0.0×FY 2017: 0.0×FY 2018: -0.0×FY 2019: -588×FY 2020: -18672×FY 2021: -2316×FY 2022: -39662×FY 2023: 207895×FY 2024: -2.7×FY 2025: -5.9×
FY 2016 5y median -5.9× FY 2025
EV/EBITDA -4.8×
FY 2016: -3.6×FY 2017: 0.1×FY 2018: -0.4×FY 2019: -1379×FY 2020: -7536×FY 2021: 12139×FY 2022: -50488×FY 2023: -17685×FY 2024: -2.2×FY 2025: -4.8×
FY 2016 5y median -4.8× FY 2025
EV/Sales 5.0×
FY 2016: 0.0×FY 2017: 0.1×FY 2018: 0.3×FY 2019: 13608×FY 2020: 41381×FY 2021: 207509×FY 2022: 254031×FY 2023: 2435×FY 2024: 14.2×FY 2025: 5.0×
FY 2016 5y median 2435× FY 2025
FCF Yield -16.9%
FY 2016: -278757.8%FY 2017: 119024.9%FY 2018: -5751.7%FY 2019: -0.2%FY 2020: -0.0%FY 2021: -0.0%FY 2022: -0.0%FY 2023: 0.0%FY 2024: -37.7%FY 2025: -16.9%
FY 2016 5y median -0.0% FY 2025

Profitability

Gross Margin 42.2%
FY 2016: 0.0%FY 2017: 99.5%FY 2018: 100.0%FY 2019: 46.0%FY 2020: -93.9%FY 2021: -250.2%FY 2022: -174.9%FY 2023: -18.3%FY 2024: -9.1%FY 2025: 42.2%
FY 2016 5y median -18.3% FY 2025
Operating Margin -103.4%
FY 2016: 0.0%FY 2017: 70.2%FY 2018: -89.0%FY 2019: -1092.0%FY 2020: -170.0%FY 2021: -8654.2%FY 2022: -536.6%FY 2023: -47.0%FY 2024: -695.4%FY 2025: -103.4%
FY 2016 5y median -536.6% FY 2025
Net Margin -49.8%
FY 2016: 0.0%FY 2017: 48.4%FY 2018: -553.6%FY 2019: -1081.2%FY 2020: -750.1%FY 2021: -8654.2%FY 2022: -536.6%FY 2023: -47.0%FY 2024: -695.4%FY 2025: -49.8%
FY 2016 5y median -536.6% FY 2025
ROE -6.4%
FY 2016: -64.7%FY 2017: 52.4%FY 2018: -11835.1%FY 2019: -83.5%FY 2020: 8314.0%FY 2021: -384.7%FY 2022: -181.7%FY 2023: -19.9%FY 2024: -192.9%FY 2025: -6.4%
FY 2016 5y median -181.7% FY 2025
ROIC -13.3%
FY 2016: -15.3%FY 2017: 69.9%FY 2018: -371.7%FY 2019: -59.6%FY 2020: -305.7%FY 2021: -376.1%FY 2022: -181.7%FY 2023: -19.9%FY 2024: -192.9%FY 2025: -13.3%
FY 2016 5y median -181.7% FY 2025
ROA -6.1%
FY 2016: -13.6%FY 2017: 46.6%FY 2018: -1544.6%FY 2019: -57.7%FY 2020: -1179.0%FY 2021: -376.1%FY 2022: -181.7%FY 2023: -18.7%FY 2024: -186.2%FY 2025: -6.1%
FY 2016 5y median -181.7% FY 2025

Growth (YoY)

Revenue -9.7%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: -79.4%FY 2019: -84.9%FY 2020: 183.7%FY 2021: -73.8%FY 2022: 170.4%FY 2023: 4.3%FY 2024: -34.9%FY 2025: -9.7%
FY 2016 FY 2025
Operating Income 86.6%
FY 2016: 9.7%FY 2017: 2217.2%FY 2018: -126.0%FY 2019: -85.1%FY 2020: 55.8%FY 2021: -1235.2%FY 2022: 83.2%FY 2023: 90.9%FY 2024: -863.7%FY 2025: 86.6%
FY 2016 FY 2025
EPS (diluted) 100.0%
FY 2016: 24.5%FY 2017: 150.0%FY 2018: -118.4%FY 2019: 100.0%FY 2020: 77.2%FY 2021: 77.8%FY 2022: 50.0%FY 2023: -200.0%FY 2024: 66.7%FY 2025: 100.0%
FY 2016 FY 2025
Free Cash Flow 76.1%
FY 2016: 0.0%FY 2017: 4229.8%FY 2018: -205.0%FY 2019: 39.5%FY 2020: 72.8%FY 2021: -960.5%FY 2022: 80.7%FY 2023: 100.2%FY 2024: -29879.4%FY 2025: 76.1%
FY 2016 FY 2025

Financial Health

Current Ratio 15.1×
FY 2016: 6.7×FY 2017: 0.4×FY 2018: 3.0×FY 2019: 4.7×FY 2020: 1.8×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 8.1×FY 2024: 17.2×FY 2025: 15.1×
FY 2016 5y median 8.1× FY 2025
Quick Ratio 14.2×
FY 2016: 6.7×FY 2017: 0.1×FY 2018: 3.0×FY 2019: 4.7×FY 2020: 1.8×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 7.2×FY 2024: 14.9×FY 2025: 14.2×
FY 2016 5y median 7.2× FY 2025
Debt / Equity 0.0×
FY 2016: 2.2×FY 2017: 0.1×FY 2018: 4.1×FY 2019: 0.2×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA 3.3×
FY 2016: -3.6×FY 2017: 0.1×FY 2018: -0.3×FY 2019: -0.2×FY 2020: 0.0×FY 2021: -1.0×FY 2022: 0.0×FY 2023: 0.1×FY 2024: 0.0×FY 2025: 3.3×
FY 2016 5y median 0.0× FY 2025
Interest Coverage 0.0×
FY 2016: 0.0×FY 2017: 430×FY 2018: -29.4×FY 2019: 0.0×FY 2020: -5.5×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31